Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04207359 · ClinicalTrials.gov registry record · NA
Effects of Creatine Supplementation in Breast Cancer Survivors
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04207359 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 20 participants.
The verdict
NCT04207359, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that creatine will accelerate adaptations associated with exercise in breast cancer survivors recently completing chemotherapy.
Interventions
- DIETARY_SUPPLEMENT Creatine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-09-30 |
| Est. Completion | 2023-03-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04207359
The ClinicalTrials.gov registry entry for NCT04207359 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Creatine is the first listed.
NCT04207359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04207359 about?
NCT04207359 is a clinical study titled "Effects of Creatine Supplementation in Breast Cancer Survivors". The purpose of this study is to test the hypothesis that creatine will accelerate adaptations associated with exercise in breast cancer survivors recently completing chemotherapy.
What is the current status of trial NCT04207359?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-09-30. Estimated completion is 2023-03-07.
What interventions are being tested in trial NCT04207359?
The interventions under investigation include: Creatine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04207359?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.